Shalby’s stock jumped 3% following the announcement that its U.S. subsidiary, Shalby Advanced Technologies (SAT) Inc., received FDA 510(k) Premarket Notification Clearance for its Duraniom™ knee replacement device. As of 9:43 AM, Shalby shares were trading 3.19% higher at Rs 229.77.
The innovative product features a durable TiNbN coating, aimed at improving patient outcomes. The FDA clearance, granted on January 14, 2025, confirms the device’s safety and effectiveness, establishing its substantial equivalence to existing market devices. This milestone positions Shalby for growth in the medical technology space.
Shalby shares opened today at ₹227.00, reaching a high of ₹233.65 and a low of ₹225.58. The stock has a 52-week high of ₹339.50 and a low of ₹204.05.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
